Who is speaking
Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable sharing of knowledge and facilitate idea exchange.
If you have a cutting edge case study or relevant presentation and would like to join the speaker panel at one of our events, please contact Penny Abernethy at p.abernethy@oxfordglobal.co.uk
Confirmed speakers for 2013
- Nataliya Afonina
Director clinical release & stability testing, BMS - Debra Brennan
Senior Scientist, Boehringer-Ingelheim - Katharine Cain
Senior Scientist, UCB - Ho Cho
CTO, Ambrx - Ciaran Cronin
Head, parallel protein production, Pfizer - Jérôme Célérier
Senior Scientist, Sisene - Gerhardus de Jong
Ultrecht University Professor, Biomolecular Analysis - Michael Doyle
Senior Principal Scientist and Group Leader, Bristol-Myers Squibb - James Errey
Associate Director Protein Biochemsitry, Heptares - Markus Eser
Head of Protein Chemistry, Affimed - Brian Fennell
Principal Scientist Global Biotherapeutics Technologies, Pfizer - Bernd Gerhartz
Director Head of Protein Science Group, Novartis - Tariq Ghayur
Senior Research Fellow, Abbott - Boris Gorovits
Director, Pfizer - Maria Groves
Senior Scientist, Lead Generation, ADPE, MedImmune - Steffen Hartmann
Global Head Protein Developability, Integrated Biologics Profiling, Novartis - Sandro Keller
Professor, Molecular Biophysics Group, University of Kaiserslautern - Alastair Lawson
VP Structural Biology, UCB - Alexey Lugovskoy
Senior Director of Therapeutic Design, Merrimack - Lorenz Mayr
Executive Director, AstraZeneca
- Andreas Menrad
CSO, Ablynx - Dario Neri
Professor, ETH Zurich - Karyn O'Neils
CSO, Centyrex - Joel Richard
VP, Ipsen - Andrew Sanderson
Principal Scientist, GSK - David Satijn
Associate Director Antibody Science, Genmab - Ralf Schumacher
VP & Head of Large Moleculte Research, Roche - Manfred Schuster
COO, Apeiron Biologics - Arne Skerra
Professor TU Munchen, Founder & CEO, XL-protein - Stefan Stahl
Professor, Dean, School of Biotechnology, KTH – Royal Institute of Technology - Albert Stewart
Director Structural Biology, Pfizer - Ali Tehrani
CEO, Zymeworks - Bernhardt Trout
Professor Of Chemical Engineering, MIT - Alex Weidenmann
Project Manager Multispecifics, Pieris AG - Trevor Wilkinson
Associate Director, Protein Sciences, Lead Generation, Department of Antibody Discovery and Protein Engineering, MedImmune - William Winston
Head Antibody Engineering, Aveo Oncology - Ulrich Wuellner
Senior Scientist, Covagen
